MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Mir

<< Previous

Bullboard Posts

Next >>

Comment by Red~Oneon Feb 18, 2021 10:46am

142 Views

Post# 32595286

RE:RE:Mir

Yes and no, what the article say is that the FDA admits it allowed too many serology tests and that users were reading the data wrong an assuming it was testing for Covid infection whereas it was also seeing past infections and giving misleading data. Ergo the FDA are saying between the lines that they want more accurate tests that test for antibodies (and in my thinking it would follow that MIR Reveal Plus would be the one to use.) Just My opinion

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China